Clinical characteristic | Category | N(%) |
---|---|---|
Sex | Male | 148 (73.3) |
Female | 54 (26.7) | |
Age(years) | <60 | 130 (64.4) |
≥61 | 72 (35.6) | |
Tumor site | Tongue | 93 (46.0) |
Buccal mucosa | 33 (16.3) | |
Gingiva | 40 (19.8) | |
Floor of mouth | 18 (8.9) | |
Palate | 8 (4.0) | |
Lip | 4 (2.0) | |
Lymph node in the neck | 6 (3.0) | |
T stage | T1(primary) | 29 (14.36) |
T2(primary) | 53 (26.24) | |
T3(primary) | 26 (12.87) | |
T4(primary) | 47 (23.27) | |
Relapse & metastasis | 47 (23.27) | |
N stage | N0(primary+relapse) | 95 + 28 (60.89) |
N+(primary+relapse) | 60 + 19 (39.11) | |
Clinical stage | I | 25 (12.38) |
II | 40 (19.80) | |
III | 25 (12.38) | |
IV | 65 (32.18) | |
Relapse | 47 (23.27) | |
Primary or relapse | Primary | 155 (76.73) |
Relapse | 47 (23.27) | |
Preoperative D-dimer (μg/L) | Median | 358.47 |
First and third quality | 184.36, 581.74 | |
Preoperative FIB (g/L) | Median | 3.56 |
First and third quality | 2.88, 4.08 | |
Preoperative PLT (10^9/L) | Median | 246.5 |
First and third quality | 210.00, 305.00 |